Offerings Archives - Page 5 of 166

1 minute read

What’s Going On With GT Biopharma Stock Tuesday?

May 21, 11:59 AM

GT Biopharma entered into a definitive securities purchase agreement for the purchase and sale of 740,000 shares of its common stock at a purchase price of $4.35 per share. The shares will be offered in a registered direct offering priced at-the-market under Nasdaq rules.

GTBP

1 minute read

Gray Television Earlier Announced It Intends To Offer Up To $1B Aggregate Principal Amount Of Senior Secured First Lien Notes Due 2029

By Benzinga Newsdesk

May 20, 12:41 PM

Gray Television, Inc. ("Gray," "we," "us" or "our") (NYSE:GTN) announced today that it intends to offer up to $1 billion aggregate principal amount of senior secured first lien notes due 2029, subject to market

GTN

1 minute read

Genius Group ExercisesCertain Outstanding Series 2024-C Warrants To Purchase Up To An Aggregate Of 10,950,451 Of The Co’s Shares Originally Issued In January 2023, At The Current Exercise Price Of $0.35 Per Share For $3.8M Of Gross Proceeds

By Benzinga Newsdesk

May 20, 8:22 AM

Genius Group Limited (NYSE:GNS) ("Genius Group" or the "Company"), a leading AI-powered education group, today announced the entry into definitive agreements for the immediate exercise of certain outstanding Series

GNS

1 minute read

Foghorn Prices $110M Registered Direct Offering Of 12,743,039 Common Stock At A Price Of $5.51 Per Share And Pre-Funded Warrants To Purchase Up To An Aggregate Of 7,220,794 Shares Of Its Common Stock At A Price Of $5.5099 Per Pre-Funded Warrant

By Benzinga Newsdesk

May 20, 8:02 AM

Foghorn Therapeutics Inc. ("Foghorn") (NASDAQ:FHTX) today announced the pricing of a registered direct offering of 12,743,039 shares of its common stock at a price of $5.51 per share, before underwriting discounts and

FHTX

2 minute read

Alta Equipment Group Announces Proposed Private Offering of $500M of Senior Secured Second Lien Notes

By Benzinga Newsdesk

May 20, 7:36 AM

Alta Equipment Group Inc. (NYSE:ALTG) ("Alta" or the "Company"), today announced that it intends to offer, subject to market and other conditions, $500 million in aggregate principal amount

ALTG

1 minute read

Comstock on May 17, Announced Private Placement of 1.25M Restricted Shares at $0.40/Share to the Chairman & CEO

By Benzinga Newsdesk

May 20, 6:30 AM

On May 17, 2024, Comstock Inc. (“Comstock”) announced the private placement of 1,250,000 restricted shares at a price of $0.40 per share, or $500,000 in net proceeds, to the Executive

LODE

1 minute read

Virios Therapeutics Announces $2.1M Proposed Public Offering Of Common Stock

By Benzinga Newsdesk

May 17, 4:11 PM

Virios Therapeutics, Inc. (NASDAQ:VIRI) (the "Company" or "Virios Therapeutics"), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, including

VIRI

1 minute read

Why Is GameStop Stock Crashing Premarket After Early Gains?

By Shanthi Rexaline

May 17, 8:36 AM

GameStop filed a prospectus with the SEC for an "at-the-market" offering, allowing them to sell up to 4.5 million common shares.

GME

1 minute read

Dermata Therapeutics Entred Agreements For The Immediate Exercise Of Certain Warrants To Purchase Up To An Aggregate Of 516,336 Shares Of The Co’s Common Stock, Having Exercise Prices Of $9.7665 And $32.40 Per Share

By Benzinga Newsdesk

May 17, 8:36 AM

Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases and conditions, today announced the

DRMA

1 minute read

Gates Prices Secondary Offering Of 17.5M Ordinary Shares

By Benzinga Newsdesk

May 16, 8:43 AM

Gates Industrial Corporation plc (NYSE:GTES, ", Gates", or the ", Company", )))) announced today the pricing of the previously announced secondary offering of 17,500,000 ordinary shares (the "Offering") by certain

GTES